相似文献
1
Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities.
Mov Disord Clin Pract. 2024 Jan;11(1):14-20. doi: 10.1002/mdc3.13903. Epub 2023 Nov 29.
2
International Genetic Testing and Counseling Practices for Parkinson's Disease.
Mov Disord. 2023 Aug;38(8):1527-1535. doi: 10.1002/mds.29442. Epub 2023 Jun 13.
3
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.
4
[Genetic testing for Parkinson's disease: indication and practical implementation].
Fortschr Neurol Psychiatr. 2020 Sep;88(9):601-608. doi: 10.1055/a-1155-6389. Epub 2020 Jun 28.
5
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Brain. 2019 Sep 1;142(9):2828-2844. doi: 10.1093/brain/awz191.
6
Test for LRRK2 mutations in patients with Parkinson's disease.
Pract Neurol. 2008 Dec;8(6):381-5. doi: 10.1136/jnnp.2008.162420.
7
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.
Mov Disord. 2023 Dec;38(12):2241-2248. doi: 10.1002/mds.29617. Epub 2023 Sep 26.
8
Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
Brain. 2009 Dec;132(Pt 12):3298-307. doi: 10.1093/brain/awp244.
9
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities.
Lancet Neurol. 2013 May;12(5):514-24. doi: 10.1016/S1474-4422(13)70047-4. Epub 2013 Apr 11.
10
A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.
J Parkinsons Dis. 2020;10(3):1195-1207. doi: 10.3233/JPD-202019.
引用本文的文献
1
Barriers to clinical genetic testing in movement disorders.
Curr Opin Neurol. 2025 Aug 1;38(4):355-360. doi: 10.1097/WCO.0000000000001381. Epub 2025 May 21.
2
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant.
NPJ Parkinsons Dis. 2025 Feb 23;11(1):34. doi: 10.1038/s41531-025-00884-6.
3
Global Perspectives on Returning Genetic Research Results in Parkinson Disease.
Neurol Genet. 2024 Dec 5;10(6):e200213. doi: 10.1212/NXG.0000000000200213. eCollection 2024 Dec.
4
Parkinson's Disease is Predominantly a Genetic Disease.
J Parkinsons Dis. 2024;14(3):467-482. doi: 10.3233/JPD-230376.
本文引用的文献
1
[Genetic revolution: New challenges and opportunities].
Rev Med Chil. 2022 Nov;150(11):1547-1548. doi: 10.4067/S0034-98872022001101547.
2
Genetic Movement Disorders Commonly Seen in Asians.
Mov Disord Clin Pract. 2023 May 8;10(6):878-895. doi: 10.1002/mdc3.13737. eCollection 2023 Jun.
3
The lived experience of stigma and parkinson's disease in Kenya: a public health challenge.
BMC Public Health. 2023 Feb 20;23(1):364. doi: 10.1186/s12889-023-15278-7.
4
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Mov Disord. 2023 Feb;38(2):286-303. doi: 10.1002/mds.29288. Epub 2023 Jan 24.
5
MDSGene: Extending the List of Isolated Dystonia Genes by VPS16, EIF2AK2, and AOPEP.
Mov Disord. 2023 Mar;38(3):507-508. doi: 10.1002/mds.29327. Epub 2023 Jan 20.
6
Health care implications of the Genetic Non-Discrimination Act: Protection for Canadians' genetic information.
Can Fam Physician. 2022 Sep;68(9):643-646. doi: 10.46747/cfp.6809643.
7
Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.
Mov Disord. 2022 Aug;37(8):1593-1604. doi: 10.1002/mds.29126. Epub 2022 Jul 22.
8
Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.
JAMA Neurol. 2022 Sep 1;79(9):929-936. doi: 10.1001/jamaneurol.2022.1783.
9
Is there a way to reduce the inequity in variant interpretation on the basis of ancestry?
Am J Hum Genet. 2022 Jun 2;109(6):981-988. doi: 10.1016/j.ajhg.2022.04.012.
10
Autosomal Recessive Cerebellar Ataxias in South America: A Multicenter Study of 1338 Patients.
Mov Disord. 2022 Aug;37(8):1773-1774. doi: 10.1002/mds.29046. Epub 2022 May 4.
Zotero 插件